Flamingo Therapeutics

Leuven, Belgium

Flamingo Therapeutics is pioneering RNA-targeted therapies for oncology.

$1.9M raised

Jun 2023

Grant

Biopharma Biotechnology Oncology

Top Investors

Agentschap Innoveren & Ondernemen

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Flamingo Therapeutics

How much funding has Flamingo Therapeutics raised?

Flamingo Therapeutics has raised $1.9M in total funding. The most recent round was Grant. The last funding was announced in June 2023.

Who are Flamingo Therapeutics's investors?

Flamingo Therapeutics's investors include Agentschap Innoveren & Ondernemen.

Where is Flamingo Therapeutics headquartered?

Flamingo Therapeutics is headquartered in Leuven, Belgium.

What does Flamingo Therapeutics do?

Flamingo Therapeutics is pioneering RNA-targeted therapies for oncology.

What stage is Flamingo Therapeutics at?

Flamingo Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 15, 2023.

MLA

"Flamingo Therapeutics — Funding & Investors." VCBacked, June 15, 2023, https://www.vcbacked.co/company/flamingo-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2023). Flamingo Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/flamingo-therapeutics

Wikipedia (cite web)

{{cite web |title=Flamingo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/flamingo-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 15, 2023.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.